Biography/Memoir

BBC… promoting marketing scheme for microdosing psychedelics

Advertising disguised as news is hardly a new trick.  [Speculators & Venture Capitalists] “with the concept of the übermensch as popularized by Nietszche…”—appear ready to cash in on vague notions of transcending humanity via drug-induced consciousness. In fact, these are precisely the types of marketing strategies we should expect to see within a nascent “psychedelic industry,”…

READ MORE
Biography/Memoir

Cannabis capitalism: who is making money in the marijuana industry?

Insiders often refer to the “cannabis space” – a term broad enough to include a social justice movement and unapologetic capitalism – and recognize no contradiction between them. In Steve Schain’s view, even the largest and most professionally run companies are being built to be acquired when major agriculture, alcohol and pharmaceutical companies consider it…

READ MORE
Biography/Memoir

…psychedelic wonder drug is almost here[?]

[Some] micro-doser[s] [claim he/she/they] doesn’t have time for an eight-hour-long trip. They have businesses to scale. … [however, research] supports the idea that… [visionary states] play a significant role in patient recovery. “They come to a profound shift of worldview, essentially a shift in a sense of self,” Griffiths said on the same segment. “Their…

READ MORE
Biography/Memoir

Psilocybin microdosing… how much is too much?

Mushroom expert Paul Stamets cautions that there can be a difference… between batches of the same species. Despite these variables, some rough calculations can be done that may provide some insight for microdosing dried mushrooms. How does 0.5 – 2.0 mg (0.0005 – 0.002 g) of psilocybin translate into a dose of dried psilocybin mushroom…

READ MORE
Biography/Memoir

What the future holds for [psychedelic mushrooms]

“We’re talking about several thousands… that are suffering every day that treatment continues to be withheld from them,” Bruce Tobin [of the University of Toronto launched the Centre for Psychedelic Studies] said. “Treatment delayed is treatment denied.” [Dana Larsen], the longtime cannabis rights advocate from Vancouver is known for protesting against drug laws… has now…

READ MORE
Biography/Memoir

…psilocybin trial data explores group psychedelic sessions

The motivation behind these group dosage experiments is primarily about exploring ways to streamline the treatment process… [COMPASS claims] scheduling more than one patient at a time offers the potential for accelerating the pace of clinical trials. However, it is worth noting, this particular study was conducted with psychologically healthy individuals, and not subjects suffering…

READ MORE